The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
 
Andreas Nicholas Saltos
No Relationships to Disclose
 
Tawee Tanvetyanon
No Relationships to Disclose
 
Charles C. Williams
Speakers' Bureau - Celgene
 
Eric B. Haura
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen Oncology
Research Funding - Boehringer Ingelheim; FORMA Therapeutics; Ignyta; Janssen; Lilly
Patents, Royalties, Other Intellectual Property - Patent pending on PLA technology related to kinase inhibitor sensitivity biomarkers
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Ben C. Creelan
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene
Speakers' Bureau - ARIAD; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Scott Joseph Antonia
Stock and Other Ownership Interests - Cellular Biomedicine Group
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
 
Nishan Tchekmedyian
Stock and Other Ownership Interests - Biomarin (I); Exelixis (I); global therapeutics (I); Halozyme (I); Infinity Pharmaceuticals (I); Portola Pharmaceuticals; Trillium Therapeutics (I)
Consulting or Advisory Role - IntrinsiQ; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - IntrinsiQ
 
Kristen Goas
No Relationships to Disclose
 
Trevor Mamplata
No Relationships to Disclose
 
Ram Thapa
No Relationships to Disclose
 
Dung-Tsa Chen
Research Funding - Abbvie (Inst)
 
Amer A. Beg
Research Funding - Celgene
 
Jhanelle Elaine Gray
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Genentech/Roche; Janssen; Lilly
Speakers' Bureau - Genentech
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Epic Sciences (Inst); Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche; Janssen Oncology